نتایج جستجو برای: transarterial chemoembolization

تعداد نتایج: 4521  

2014
WENBO SHAO FENGJUAN ZHANG NING CONG JINPENG LI JINLONG SONG

Sorafenib has been demonstrated to improve survival rate in patients with advanced hepatocellular carcinoma (HCC); however, the survival benefit remains modest and the response rates remain poor. Transarterial chemoembolization (TACE) may be used for the treatment of advanced HCC with well-preserved liver function and has a high local tumor control rate. We hypothesized that patients with advan...

2017
Andrea Casadei Gardini Daniele Santini Giuseppe Aprile Nicola Silvestris Emanuele Felli Francesco Giuseppe Foschi Giorgio Ercolani Giorgia Marisi Martina Valgiusti Alessandro Passardi Marco Puzzoni Marianna Silletta Oronzo Brunetti Giovanni Gerardo Cardellino Giovanni Luca Frassineti Mario Scartozzi

Transarterial chemoembolization (TACE) is the standard treatment for intermediate stage, although the combination of TACE with sorafenib may theoretically benefit HCC patients in intermediate stage. Owing to the significant antiangiogenic effect of sorafenib and the limitation of TACE, it is rational to combine them. Though the strategy of combining TACE and sorafenib has been increasingly used...

2009
Sung Wook Shin

Despite remarkable advancement in the surveillance and treatment of hepatocellular carcinoma (HCC) and the availability of novel curative options, a great proportion of HCC patients are still not eligible for curative treatment due to an advanced tumor stage or poor hepatic functional reserve. Therefore, there is a continuing need for effective palliative treatments. Although practiced widely, ...

Journal: :Journal of Clinical and Experimental Hepatology 2015

2011
Alexander F. Hagel Wolfgang H. Hagel Annette S. Lindner Ferdinand J. Kammerer Markus F. Neurath Peter C. Konturek Igor A. Harsch

BACKGROUND Metastatic insulinoma is a disease associated with a poor life expectancy. CASE REPORT The case of a presently 68 year old female with malignant, metastatic insulinoma is reported. Due to severe clinical symptoms surgical tumor mass reduction was conducted. Furthermore the patient underwent a chemotherapy using streptozotocine and fluorouracil. After two years without any symptoms,...

Journal: :Digestive surgery 1999
M Falconi C Bassi A Bonora N Sartori C Procacci G Talamini G C Mansueto P Pederzoli

Endocrine tumours of the pancreas, even in case of liver involvement, are generally characterized by a slower evolution and a better prognosis, if compared with ductal carcinoma. This fact gives reason to a radical surgical approach, whenever possible, and to the research of any effective adjuvant treatment. For this purpose, hepatic transarterial chemoembolization (TACE) has been proposed in r...

2014
Stephen P. Reis Takeshi Yokoo Clayton K. Trimmer

We report the case of a 78-year-old woman with hepatocellular carcinoma who underwent drug-eluting bead transarterial chemoembolization (DEB-TACE). On the first routine follow-up CT six-weeks post procedure, the patient was found to have residual enhancing tumor and active intra-tumoral hemorrhage (Fig 1A). Follow-up laboratory values demonstrated a decrease in hemoglobin. Subsequent catheter a...

Journal: :Oncology 2009
Richard Kim Ann Tan Bassam Estfan Federico Aucejo

Hepatocellular cancer (HCC) is a major cause of mortality. Management approaches including surgical and locoregional strategies such as transarterial chemoembolization, radiofrequency ablation, ethanol injections, transarterial chemotherapy infusion, and systemic chemotherapy have proved to be disappointing. Orthotopic liver transplantation (OLT) continues to give patients the best chance for c...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید